Top Health-care stocks:
Health-care shares were mainly higher in pre-market trade Tuesday.
In health-care stocks news, Immunomedics ( IMMU ) shares are up more than 25% pre-market after the company said sacituzumab govitecan, the company's lead investigational antibody-drug conjugate, continues to produce durable responses in patients with metastatic lung cancer who had relapsed or were refractory to their last cancer therapy. The shares recently traded at $2.15.
While Inovio Pharmaceuticals ( INO ) said it has dosed the first patient in a phase I trial to evaluate safety and tolerability of PENNVAX-GP, Inovio's "universal" DNA vaccine for HIV, according to a release by the company on Tuesday.
Shares in the company were unchanged at $7.11 pre-bell. Over the past 52 weeks, the company has traded between $6.19 and $13.04.
Global Blood Therapeutics ( GBT ) shares were initiated by Cowen with an outperform rating.
Shares in the company were also flat at $52.70 pre-bell. Over the past 52 weeks, the company has traded between $33.01 and $55.44.
And Rigel Pharmaceuticals ( RIGL ) Tuesday reported the FDA has granted "orphan drug designation" to fostamatinib, Rigel's oral spleen tyrosine kinase inhibitor which is currently in phase 3 clinical trials for chronic immune thrombocytopenic purpura, a blood disorder.
Shares in the company were 0.7% higher at $3 pre-bell. Over the past 52 weeks, the company has traded between $1.56 and $5.20.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.